Premium
In vitro activity and mutagenicity of bisbenzylisoquinolines and quinones against Trypanosoma cruzi trypomastigotes
Author(s) -
de Arias A. Rojas,
Inchausti A.,
Ascurrat M.,
Fleitas N.,
Rodriguez E.,
Fournet A.
Publication year - 1994
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.2650080304
Subject(s) - trypanosoma cruzi , benznidazole , in vitro , subculture (biology) , microbiology and biotechnology , biology , alkaloid , traditional medicine , chemistry , biochemistry , botany , medicine , parasite hosting , world wide web , computer science
The accidental transmission of Chagas' disease by donor blood is recognized as a serious problem in the Latin America. This paper describes the screening of natural products as possible new chemoprophylactic additives in blood banks. Ten plant‐derived alkaloids, three terpenes, three quinones and 14 crude plant extracts were tested against bloodstream forms of Trypanosoma cruzi Y strain in vitro at 4°C at a concentration of 250 μg/mL, using gentian violet as the baseline drug. The bisbenzylisoquinoline alkaloids, cocsuline, daphnandrine, daphnoline, isochondodendrine, gyrocarpine, limacine and pheanthine and the naphthoquinone, plumbagin completely lysed the trypomastigote forms of T. cruzi at a concentration of 250 μg/mL, this activity was verified by the subculture of the treated medium during 4 months. The active alkaloids, pheanthine, daphnoline and limacine were evaluated for mutagenicity by the sister chromatid exchange assay (SCE) in peripheral lymphocytes. Daphnoline and pheanthine elicited no significant increase of the SCE up to 50 μg/mL, while limacine significantly increased the SCE values at a concentration of 25 μg/mL, and 50 μg/mL.